Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Shojiro Ikematsu"'
Autor:
Yuichi Shiokawa, Kohei Miyazono, Satoshi Kimura, Akira Ito, Fumimaro Takaku, Juzo Matsuda, Mikio Minamitani, T Nakahata, Shojiro Ikematsu, Kaoru Shimada
Publikováno v:
Aids. 4:1251-1256
The efficacy of recombinant human granulocyte colony-stimulating factor (rhG-CSF) on neutropenia was evaluated in 14 patients with AIDS and AIDS-related complex (ARC). In all patients, including 11 neutropenic patients, 100 or 200 micrograms/m2 of rh
Publikováno v:
Japanese Journal of Thrombosis and Hemostasis. 1:219-224
Publikováno v:
Thrombosis research. 82(2)
A heterozygote for congenital deficiency of plasma plasmin inhibitor had hemorrhagic episodes repeatedly after the age of 79. Before the age of 79, he had not exhibited any hemorrhgic tendency and did not have abnormal bleeding even after surgical op
Autor:
Hisashi Yorifuji, Katsuhiro Fukutake, Hiroshi Nagasawa, Michio Fujimaki, Toshihito Katsumura, Hisao Iwane, Shojiro Ikematsu, Morio Arai, Toshihiko Ishii
Publikováno v:
Thrombosis research. 57(3)
Autor:
Katsuhiro Fukutake, Shojiro Ikematsu, Michiko Fujimaki, Shinjin Konishi, Masatoshi Kato, Tomohiro Samori, Motohiro Yatabe, Ohki Itoh
Publikováno v:
Blood & Vessel. 8:628-632
Autor:
Takeshi Abe, Akira Shirahata, Hoyu Takahashi, Takeshi Nagao, Yoji Ohkawa, Fumio Bessho, Mitsuru Shirakawa, Shojiro Ikematsu, Yasuhiko Hiyoshi, Atsuko Hifumi
Publikováno v:
Blood & Vessel. 18:448-455
Hepatitis infection in haemophiliacs has been a major problem in their replacement therapy, and factor VIII concentrates manufactured from pooled plasma were realized to be the cause of transmission of AIDS virus. However, several investigators have
Autor:
Takeshi Kitahara, Minoru Ukita, Hiroshi Nagasawa, Eiji Takahashi, Yasuhisa Matsubara, Katsuyuki Fukutake, Tomohiro Samori, Masao Hada, Michio Fujimaki, Katsuhiro Fukutake, Shojiro Ikematsu
Publikováno v:
Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 12:359-375
The phase one study was performed by the use of the single and multiple intravenous administration of newly developed synthetic antithrombin agent: (2 R, 4 R)-4-methyl-l- [N2- [(3-methyl-1, 2, 3, 4-tetrahydro-8-quinolinesulfonyl)-Larginyl] -2-piperid
Autor:
Izumi Takeuchi, Katsuhiro Fukutake, Akihiko Okubo, Tomohiro Samori, Shojiro Ikematsu, Michio Fujimaki, Masatoshi Kato
Publikováno v:
Blood & Vessel. 7:141-145
Publikováno v:
Blood & Vessel. 13:183-189
Autor:
Shojiro Ikematsu
Publikováno v:
Blood & Vessel. 16:1-12